Literature DB >> 2987275

Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.

W A Marasco, D E Feltner, P A Ward.   

Abstract

To examine the existence of negative cooperativity among formyl peptide chemotaxis receptors, steady-state binding of f Met-Leu-[3H]Phe to viable rat neutrophils and their purified plasma membranes was measured and the data were subjected to statistical analysis and to computer curve fitting using the NONLIN computer program. Curvilinear, concave upward Scatchard plots were obtained. NONLIN and statistical analysis of the binding data indicated that a two-saturable-sites model was preferable to a one-saturable-site model and statistically valid by the F-test (P less than .010). In addition, Hill coefficients of 0.80 +/- 0.02 were obtained. Kinetic dissociation experiments using purified plasma membranes showed evidence of site-site interactions of the destabilizing type (negative cooperativity). Thus, unlabeled f Met-Leu-Phe accelerated the dissociation of f Met-Leu-[3H]Phe under conditions where no rebinding of radioligand occurred. The rate of dissociation of f Met-Leu-[3H]Phe from the plasma membranes was dependent on the fold excess of unlabeled f Met-Leu-Phe used in the dilution medium; at the highest concentration tested (10,000-fold excess), the dissociation rate was more than double the dissociation rate seen with dilution alone. In addition, occupancy-dependent affinity was ascertained directly by studying the effect of increasing fractional receptor saturation with labeled ligand on the dissociation rate of the receptor-bound labeled ligand. These data showed that the f Met-Leu-[3H]Phe dissociation rate was dependent on the degree of binding site occupancy over the entire biologically relevant range of formyl peptide concentrations. Furthermore, monitoring of the time course of dissociation of the receptor/f Met-Leu-[3H]Phe receptor/f Met-Leu-[3H]Phe complex as a function of receptor occupancy revealed that receptor affinity for f Met-Leu-Phe remained occupancy-dependent during the entire time of dissociation examined (up to 10 min). Finally, the average affinity profile of the equilibrium binding data demonstrated a 60% decrease in receptor affinity in changing from the high affinity to the low affinity conformation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987275     DOI: 10.1002/jcb.240270406

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  The significance of functional receptor heterogeneity in the biological responses of the rabbit neutrophil to stimulation by chemotactic formyl peptides.

Authors:  J C Kermode; R J Freer; E L Becker
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Utilization of extracellular information before ligand-receptor binding reaches equilibrium expands and shifts the input dynamic range.

Authors:  Alejandra C Ventura; Alan Bush; Gustavo Vasen; Matías A Goldín; Brianne Burkinshaw; Nirveek Bhattacharjee; Albert Folch; Roger Brent; Ariel Chernomoretz; Alejandro Colman-Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-29       Impact factor: 11.205

3.  Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.

Authors:  W Zimmerli; B Seligmann; J I Gallin
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.

Authors:  J W Kazura; J D Wenger; R A Salata; A Z Budzynski; G H Goldsmith
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

Authors:  Y H Atkinson; W A Marasco; A F Lopez; M A Vadas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.